Elite Pharmaceuticals, Inc. Finance Lease, Liability, Undiscounted Excess Amount
Elite Pharmaceuticals, Inc. (ELTP) had Finance Lease, Liability, Undiscounted Excess Amount of $156.27 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-13
- 2026-06-30: Finance Lease, Liability, Undiscounted Excess Amount $156.27K.
- 2026-03-31: Finance Lease, Liability, Undiscounted Excess Amount $184.86K.
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $215.71K.
- 2025-09-30: Finance Lease, Liability, Undiscounted Excess Amount $248.85K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $156.27K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $184.86K 10-K · filed 2026-06-29 |
| 2025-12-31 | $215.71K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $248.85K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $284.22K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $321.78K 10-K · filed 2025-06-30 |
| 2024-12-31 | $361.47K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $403.24K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $413.51K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $453.36K 10-K · filed 2024-07-01 |
| 2023-12-31 | $81.91K 10-Q · filed 2024-02-14 |